Evidence map›Paper›PMID 39062917›Full record

ArticleInternational journal of molecular sciences2024

Genomic Landscape of Susceptibility to Severe COVID-19 in the Slovenian Population.

Anja Kovanda, Tadeja Lukežič, Aleš Maver, Hana Vokač Križaj, Mojca Čižek Sajko, Julij Šelb, Matija Rijavec, Urška Bidovec-Stojković, Barbara Bitežnik, Boštjan Rituper and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anja KovandaClinical Institute of Genomic Medicine, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0002-7468-878X
Tadeja LukežičClinical Institute of Genomic Medicine, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Aleš MaverClinical Institute of Genomic Medicine, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Hana Vokač KrižajClinical Institute of Genomic Medicine, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Mojca Čižek SajkoClinical Institute of Genomic Medicine, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Julij ŠelbUniversity Clinic of Respiratory and Allergic Diseases Golnik, 4204 Golnik, Slovenia.
Matija RijavecUniversity Clinic of Respiratory and Allergic Diseases Golnik, 4204 Golnik, Slovenia.ORCID 0000-0002-2596-4952
Urška Bidovec-StojkovićUniversity Clinic of Respiratory and Allergic Diseases Golnik, 4204 Golnik, Slovenia.ORCID 0000-0001-8978-6887
Barbara BitežnikUniversity Clinic of Respiratory and Allergic Diseases Golnik, 4204 Golnik, Slovenia.
Boštjan RituperUniversity Clinic of Respiratory and Allergic Diseases Golnik, 4204 Golnik, Slovenia.
Peter KorošecUniversity Clinic of Respiratory and Allergic Diseases Golnik, 4204 Golnik, Slovenia.
Borut PeterlinClinical Institute of Genomic Medicine, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.

Funding

SIRT3, Mitochondrial Dysfunction, and Alzheimers Disease PathogenesisZIAAG000326 · NIA · NATIONAL INSTITUTE ON AGING · PI MATTSON, MARK · 2017 to 2018
$833k
Slovenian Research Agency ARRS-RPROG-JP-COVID19-Prijava/2020/091Slovenian Research Agency P3-0326Slovenian Research Agency P3-0360
6 · The paper itself

Abstract

Determining the genetic contribution of susceptibility to severe SARS-CoV-2 infection outcomes is important for public health measures and individualized treatment. Through intense research on this topic, several hundred genes have been implicated as possibly contributing to the severe infection phenotype(s); however, the findings are complex and appear to be population-dependent. We aimed to determine the contribution of human rare genetic variants associated with a severe outcome of SARS-CoV-2 infections and their burden in the Slovenian population. A panel of 517 genes associated with severe SARS-CoV-2 infection were obtained by combining an extensive review of the literature, target genes identified by the COVID-19 Host Genetic Initiative, and the curated Research COVID-19 associated genes from PanelApp, England Genomics. Whole genome sequencing was performed using PCR-free WGS on DNA from 60 patients hospitalized due to severe COVID-19 disease, and the identified rare genomic variants were analyzed and classified according to the ACMG criteria. Background prevalence in the general Slovenian population was determined by comparison with sequencing data from 8025 individuals included in the Slovenian genomic database (SGDB). Results show that several rare pathogenic/likely pathogenic genomic variants in genes

Indexed as

COVID-19Genetic Predisposition to DiseaseSARS-CoV-2AdultAgedFemaleGenetic VariationGenomicsHumansMaleMiddle AgedPandemicsSloveniaWhole Genome Sequencinggenetic susceptibilityhuman rare genomic variantsrare variantssevere COVID-19severe outcome of SARS-CoV-2 infectionWGSwhole-genome sequencing

Identifiers

PMID39062917
PMCPMC11277002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.